Ms. Vandenborre has been consistently named as a leading practitioner in Lexology Index guides in both competition and life sciences, as well as repeatedly in Chambers and The Legal 500 EMEA. In 2025, Ms. Vandenborre was selected to Global Competition Review’s Women in Antitrust list and named a Litigation Star for Belgium - Competition/Antitrust by Benchmark Litigation Europe. She was also honored as Antitrust & Competition Lawyer of the Year at the Women in Business Law EMEA Awards in 2023 and as Lawyer of the Year by GCR in 2022, which also recognized Ms. Vandenborre for her representation of Aspen Pharmacare in relation to the European Commission’s (EC) Article 102 investigation of the company’s pricing practices, which was named European Behavioural Matter of the Year by the publication. In addition, she has been named a Competition MVP by Law360 and Competition Lawyer of the Year at Benchmark Litigation Europe’s Awards, which also recognized the Aspen matter as an Impact Case of the Year. Ms. Vandenborre has also been recognized as one of Lawdragon’s 500 Leading Global Litigators and 500 Leading Global Antitrust & Competition Lawyers. She is also a visiting professor at the College of Europe in Bruges, Belgium.